Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
SAGE documentation
2017
Evidence to recommendation table
Clear all
Type of publications
SAGE documentation
(13)
Topics
Evidence to recommendation table
(13)
Regions
Countries
Diseases
Diphtheria
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(3)
Measles
(2)
Pneumococcal disease
(2)
Rabies
(2)
Typhoid
(1)
Publication date
2017
(13)
2022
(4)
2021
(1)
2020
(1)
2018
(8)
2016
(1)
2015
(1)
Target population
Available to download in languages
English (EN)
(13)
13 results found
2017
∙
SAGE
Evidence to recommendation table (duration)
2017
∙
SAGE
Evidence to recommendation table (birth dose)
2017
∙
SAGE
Should SAGE recommend the removal of the criterion that MCV2 only be given if MCV1 coverage is >80% for the introduction of routine measles second dose as stated in the 2009 measles vaccine position paper?
2017
∙
SAGE
Should HIV-infected children receiving highly active antiretroviral therapy be revaccinated against measles?
2017
∙
SAGE
Diphtheria evidence to recommendation table
2017
∙
SAGE
Evidence Profiles
2017
∙
SAGE
Evidence to Recommendation Tables - rabies
2017
∙
SAGE
Evidence to recommendation tables for typhoid vaccines
2017
∙
SAGE
Grade Tables - PCV
2017
∙
SAGE
In 9 to 15-year old females, is 9-valent human papillomavirus vaccine (HPV) vaccine superior to 4-valent or 2-valent HPV vaccines?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register